The optimization and validation of the Biotyper MALDI-TOF MS database for the identification of Gram-positive anaerobic cocci
OBJECTIVES: Gram-positive anaerobic cocci (GPAC) account for 24-31% of the anaerobic bacteria isolated from human clinical specimens. At present GPAC are underrepresented in the Biotyper MALDI-TOF MS database. Profiles of new species have yet to be added. We present the optimization of the MALDI-TOF...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2016
|
| Sorozat: | CLINICAL MICROBIOLOGY AND INFECTION
22 No. 9 |
| doi: | 10.1016/j.cmi.2016.06.016 |
| mtmt: | 3103951 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/12177 |
| LEADER | 02771nab a2200325 i 4500 | ||
|---|---|---|---|
| 001 | publ12177 | ||
| 005 | 20200326125433.0 | ||
| 008 | 171026s2016 hu o 0|| zxx d | ||
| 022 | |a 1198-743X | ||
| 024 | 7 | |a 10.1016/j.cmi.2016.06.016 |2 doi | |
| 024 | 7 | |a 3103951 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Veloo Alida C.M. | |
| 245 | 1 | 4 | |a The optimization and validation of the Biotyper MALDI-TOF MS database for the identification of Gram-positive anaerobic cocci |h [elektronikus dokumentum] / |c Veloo Alida C.M. |
| 260 | |c 2016 | ||
| 300 | |a 793-798 | ||
| 490 | 0 | |a CLINICAL MICROBIOLOGY AND INFECTION |v 22 No. 9 | |
| 520 | 3 | |a OBJECTIVES: Gram-positive anaerobic cocci (GPAC) account for 24-31% of the anaerobic bacteria isolated from human clinical specimens. At present GPAC are underrepresented in the Biotyper MALDI-TOF MS database. Profiles of new species have yet to be added. We present the optimization of the MALDI-TOF MS database for the identification of GPAC. METHODS: Main Spectral Profiles (MSPs) were created for 108 clinical GPAC isolates. Identity was confirmed using 16S rRNA gene sequencing. Species identification was considered to be reliable if the sequence similarity with its closest relative was >/=98.7%. The optimized database was validated using 140 clinical isolates. The 16S rRNA sequencing identity was compared with the MALDI-TOF MS result. RESULTS: MSPs were added from 17 species that were not yet represented in the MALDI-TOF MS database or were underrepresented (<5 MSPs). This resulted in an increase from 53.6% (75/140) to 82.1% (115/140) of GPAC isolates that could be identified at the species level using MALDI-TOF MS. An improved log score was obtained for 51.4% (72/140) of the strains. For strains with a sequence similarity <98.7% with their closest relative (n=5) or with an inconclusive sequence identity (n=4), no identification was obtained by MALDI-TOF MS or in the latter case an identity with one of its relatives. CONCLUSIONS: For some species the MSP of the type strain was not a part of the confined cluster of the corresponding clinical isolates. Also, not all species formed a homogeneous cluster. It emphasizes the necessity of adding sufficient MSPs of human clinical isolates. | |
| 700 | 0 | 2 | |a de Vries E. D. |e aut |
| 700 | 0 | 2 | |a Jean-Pierre Helene |e aut |
| 700 | 0 | 2 | |a Justesen Ulrik Stenz |e aut |
| 700 | 0 | 2 | |a Morris Trefor E. |e aut |
| 700 | 0 | 2 | |a Zsoldiné Urbán Edit |e aut |
| 700 | 0 | 2 | |a Wybo Ingrid |e aut |
| 700 | 0 | 2 | |a van Winkelhoff Arie Jan |e aut |
| 700 | 0 | 2 | |a ENRIA workgroup |e aut |
| 700 | 0 | 2 | |a Nagy Erzsébet |e aut |
| 700 | 0 | 2 | |a Zsoldiné Urbán Edit |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/12177/1/1_s2.0_S1198743X16302166_main_u.pdf |z Dokumentum-elérés |